These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12659056)

  • 1. Executive summary: pharmaceutical discounts under federal law: state program opportunities.
    von Oehsen WH; Ashe M; Duke K
    Am J Health Syst Pharm; 2003 Mar; 60(6):551-3. PubMed ID: 12659056
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs.
    Mello MM; Studdert DM; Brennan TA
    N Engl J Med; 2004 Feb; 350(6):608-13. PubMed ID: 14762190
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Health Policy Tracking Service, A Service of Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-21. PubMed ID: 21374837
    [No Abstract]   [Full Text] [Related]  

  • 4. Maine racks up another win. High court advised not to hear case against law.
    Tieman J
    Mod Healthc; 2002 Jun; 32(23):20-1. PubMed ID: 12096424
    [No Abstract]   [Full Text] [Related]  

  • 5. Maine's right prescription. Justices approve controversial drug-pricing law.
    Tieman J
    Mod Healthc; 2003 May; 33(21):6-7. PubMed ID: 12800282
    [No Abstract]   [Full Text] [Related]  

  • 6. Trying to get control of drug costs, Florida earns kudos--and a lawsuit.
    Carlson B
    Manag Care; 2001 Oct; 10(10):17, 21. PubMed ID: 11764743
    [No Abstract]   [Full Text] [Related]  

  • 7. Challenging pharmaceutical industry political power in Maine and Vermont.
    Castellblanch R
    J Health Polit Policy Law; 2003 Feb; 28(1):109-32. PubMed ID: 12705419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PhRMA challenges Maine's novel Rx law.
    Tieman J
    Mod Healthc; 2000 Aug; 30(34):12-3. PubMed ID: 11185156
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimates of the Number of Brand-name Drugs Affected by the Medicaid Rebate Cap in 2017.
    Dickson S
    JAMA Intern Med; 2019 Mar; 179(3):437-439. PubMed ID: 30667469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Rx for reform: a Medicare prescription drug benefit.
    Rak J
    Health Matrix Clevel; 2002; 12(2):449-505. PubMed ID: 12430363
    [No Abstract]   [Full Text] [Related]  

  • 11. Interest groups and state Medicaid drug programs.
    Pracht EE; Moore WJ
    J Health Polit Policy Law; 2003 Feb; 28(1):9-39. PubMed ID: 12705416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crossing boundaries. Big Pharma stalls discounted Maine Rx drug program.
    White C
    Revolution (Oakl); 2002; 3(6):9. PubMed ID: 12599702
    [No Abstract]   [Full Text] [Related]  

  • 13. Government commitment and regulation of prescription drugs.
    Frank RG
    Health Aff (Millwood); 2003; 22(3):46-8. PubMed ID: 12757271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug card setback highlights need for cost relief.
    Gundling RL
    Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceuticals and medical devices: Medicare Part D. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447
    [No Abstract]   [Full Text] [Related]  

  • 16. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
    Gudiksen KL; King JS
    J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534
    [No Abstract]   [Full Text] [Related]  

  • 17. Patching the patchwork quilt: "reforming" the Medicaid program--the Medicaid Voluntary Contribution and Provider-Specific Tax Amendments of 1991.
    Spivey MO
    Ann Health Law; 1992; 1():37-51. PubMed ID: 10141600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State health insurance exchange laws: the first generation.
    Rosenbaum S; Lopez N; Burke T; Dorley M
    Issue Brief (Commonw Fund); 2012 Jul; 19():1-18. PubMed ID: 22838045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HHS proposes changes to further limit Medicaid loophole.
    Health Care Financ Rev; 2001; 23(2):103-4. PubMed ID: 12500343
    [No Abstract]   [Full Text] [Related]  

  • 20. Value-Based Pricing and State Reform of Prescription Drug Costs.
    Hwang TJ; Kesselheim AS; Sarpatwari A
    JAMA; 2017 Aug; 318(7):609-610. PubMed ID: 28692713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.